Over a year has passed by since COVISHIELD vaccine, developed by the pharma giant AstraZeneca inc. and Oxford University, was launched in India. While the vaccine initially thrived in the international market, due to a controversial development, it was suspended for use by more that a dozen countries including Denmark, Germany and France.
from Times of India https://ift.tt/QFDIlJm
Wednesday, April 27, 2022
Why AstraZeneca is not the go-to vaccine for many countries https://ift.tt/ldATMhW
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment